Anti-Human CD274 Recombinant Antibody (Atezolizumab) (CAT#: TAB-418CQ)

Recombinant monoclonal antibody to CD274. Atezolizumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • IgG1, κ
  • Specificity
  • Human CD274
  • Species Reactivity
  • Human
  • Applications
  • Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry
  • Conjugate
  • Unconjugated
  • CAS
  • 1380723-44-3
  • Generic Name
  • Atezolizumab
  • UNII
  • 52CMI0WC3Y
  • Related Disease
  • Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial

Product Property

  • Purity
  • > 95% as determined by SDS-PAGE
  • Storage
  • Store at -20°C for long-term storage. Avoid freeze/thaw cycles.

Target

  • Alternative Names
  • Programmed cell death 1 ligand 1; B7H1; B7-H1; PDL1; PD-L1; PDCD1L1; B7 homolog 1; B7 homologue 1

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Atezolizumab"

Afuco™ Anti-CD274 ADCC Recombinant Antibody (Atezolizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD274. Atezolizumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial.

See other products for "Cd274"

Chimeric Antibody

Neutralizing Antibody

CAT Product Name Application Type
NEUT-324CQ Mouse Anti-CD274 Recombinant Antibody (clone 29E.2A3.C6) IHC-P, FC, Neut, ICC Mouse IgG2b, κ
NEUT-325CQ Human Anti-CD274 Recombinant Antibody (clone CBLS-206) Neut Human IgG1, κ
NEUT-326CQ Human Anti-CD274 Recombinant Antibody (clone CBLS-207) ELISA, Neut Human IgG1, κ
NEUT-327CQ Mouse Anti-CD274 Recombinant Antibody (clone MIH1) FC, FuncS, Neut, IHC, IF Mouse IgG1, κ
NEUT-330CQ Rat Anti-CD274 Recombinant Antibody (clone MIH5) FC, FuncS, Neut, IHC-Fr, WB Rat IgG2a, λ

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-417CQ Afuco™ Anti-CD274 ADCC Recombinant Antibody (Durvalumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, Inhib ADCC enhanced antibody
AFC-TAB-418CQ Afuco™ Anti-CD274 ADCC Recombinant Antibody (Atezolizumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, BL ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-418CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare